Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
Department of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Prog Neurobiol. 2018 Jun-Aug;165-167:103-116. doi: 10.1016/j.pneurobio.2018.03.002. Epub 2018 Mar 21.
Ischemic stroke is a leading cause of morbidity and death, with the outcome largely determined by the amount of hypoxia-related neuronal death in the affected brain regions. Cerebral ischemia and hypoxia activate the Notch1 signaling pathway and four prominent interacting pathways (NF-κB, p53, HIF-1α and Pin1) that converge on a conserved DNA-associated nuclear multi-protein complex, which controls the expression of genes that can determine the fate of neurons. When neurons experience a moderate level of ischemic insult, the nuclear multi-protein complex up-regulates adaptive stress response genes encoding proteins that promote neuronal survival, but when ischemia is more severe the nuclear multi-protein complex induces genes encoding proteins that trigger and execute a neuronal death program. We propose that the nuclear multi-protein transcriptional complex is a molecular mediator of neuronal hormesis and a target for therapeutic intervention in stroke.
缺血性中风是发病率和死亡率的主要原因,其结果在很大程度上取决于受影响大脑区域中与缺氧相关的神经元死亡的数量。脑缺血和缺氧会激活 Notch1 信号通路以及四个主要的相互作用通路(NF-κB、p53、HIF-1α 和 Pin1),这些通路汇聚到一个保守的与 DNA 相关的核多蛋白复合物上,该复合物控制着可以决定神经元命运的基因的表达。当神经元经历中等程度的缺血损伤时,核多蛋白复合物上调适应性应激反应基因,这些基因编码促进神经元存活的蛋白质,但当缺血更为严重时,核多蛋白复合物会诱导编码触发和执行神经元死亡程序的蛋白质的基因。我们提出,核多蛋白转录复合物是神经元适应原性的分子介体,也是中风治疗干预的靶点。